| Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins E Bartee, M Mansouri, BT Hovey Nerenberg, K Gouveia, K Früh Journal of virology 78 (3), 1109-1120, 2004 | 390 | 2004 |
| Quantitative membrane proteomics reveals new cellular targets of viral immune modulators E Bartee, A McCormack, K Früh PLoS pathogens 2 (10), e107, 2006 | 260 | 2006 |
| TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum G Hassink, M Kikkert, S VOORDEN, SJ Lee, R Spaapen, T LAAR, ... Biochemical Journal 388 (2), 647-655, 2005 | 211 | 2005 |
| Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes J Thibodeau, MC Bourgeois‐Daigneault, G Huppé, J Tremblay, A Aumont, ... European journal of immunology 38 (5), 1225-1230, 2008 | 194 | 2008 |
| Cytokine determinants of viral tropism G McFadden, MR Mohamed, MM Rahman, E Bartee Nature Reviews Immunology 9 (9), 645-655, 2009 | 171 | 2009 |
| The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4 M Mansouri, E Bartee, K Gouveia, BT Hovey Nerenberg, J Barrett, ... Journal of virology 77 (2), 1427-1440, 2003 | 161 | 2003 |
| Tumor-localized secretion of soluble PD1 enhances oncolytic virotherapy MY Bartee, KM Dunlap, E Bartee Cancer research 77 (11), 2952-2963, 2017 | 120 | 2017 |
| RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages F Wang, X Gao, JW Barrett, Q Shao, E Bartee, MR Mohamed, M Rahman, ... PLoS pathogens 4 (7), e1000099, 2008 | 118 | 2008 |
| The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts E Bartee, MR Mohamed, MC Lopez, HV Baker, G McFadden Journal of virology 83 (2), 498-511, 2009 | 109 | 2009 |
| Fueling cancer immunotherapy with common gamma chain cytokines CJ Dwyer, HM Knochelmann, AS Smith, MM Wyatt, GO Rangel Rivera, ... Frontiers in immunology 10, 263, 2019 | 105 | 2019 |
| Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses K Früh, E Bartee, K Gouveia, M Mansouri Virus Research 88 (1-2), 55-69, 2002 | 100 | 2002 |
| Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes E Bartee, CA Eyster, K Viswanathan, M Mansouri, JG Donaldson, K Früh PloS one 5 (12), e15132, 2010 | 88 | 2010 |
| Cytokine synergy: an underappreciated contributor to innate anti-viral immunity E Bartee, G McFadden Cytokine 63 (3), 237-240, 2013 | 87 | 2013 |
| Tumor necrosis factor and interferon: cytokines in harmony E Bartee, MR Mohamed, G McFadden Current Opinion in Microbiology 11 (4), 378-383, 2008 | 82 | 2008 |
| The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories BTH Nerenberg, J Taylor, E Bartee, K Gouveia, M Barry, K Früh Journal of virology 79 (1), 597-601, 2005 | 78 | 2005 |
| Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus E Bartee, WM Chan, JS Moreb, CR Cogle, G McFadden Biology of blood and marrow transplantation 18 (10), 1540-1551, 2012 | 74 | 2012 |
| Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-β E Bartee, G McFadden Cytokine 47 (3), 199-205, 2009 | 61 | 2009 |
| Oncolytic virotherapy for hematological malignancies S Bais, E Bartee, MM Rahman, G McFadden, CR Cogle Advances in virology 2012 (1), 186512, 2012 | 56 | 2012 |
| Syncytia formation in oncolytic virotherapy C Burton, E Bartee Molecular Therapy-Oncolytics 15, 131-139, 2019 | 39 | 2019 |
| Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells NY Villa, E Bartee, MR Mohamed, MM Rahman, JW Barrett, G McFadden Virology 401 (2), 266-279, 2010 | 38 | 2010 |
